FDA
-
-
-
-
-
-
-
Raymond James on Aardvark Therapeutics Inc (AARD): 'credible path' at lower dose possible
-
-
-
-
-
-
-
Morgan Stanley Downgrades Aardvark Therapeutics Inc (AARD) to Equalweight
-
-
-
-
-
-
-
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
-
-
-
-
-
-
-
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
-
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

